Published in J Cereb Blood Flow Metab on March 01, 1985
Cerebral metabolic adaptation and ketone metabolism after brain injury. J Cereb Blood Flow Metab (2007) 1.70
Cortical substrate oxidation during hyperketonemia in the fasted anesthetized rat in vivo. J Cereb Blood Flow Metab (2011) 0.90
Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol (1971) 3.26
Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev (1983) 2.46
Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem (1990) 2.45
N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev (1989) 2.28
Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U S A (1999) 1.93
Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A (1996) 1.91
The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol (1977) 1.77
Transport of metabolic substrates through the blood-brain barrier. J Neurochem (1977) 1.73
Targeting of glucose transport proteins for tumor imaging: is it feasible? J Nucl Med (1996) 1.64
Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. J Pharmacol Exp Ther (2000) 1.63
Thyroid function in nonthyroidal illnesses. Ann Intern Med (1983) 1.62
Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev (2001) 1.62
Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy. Ann Neurol (1990) 1.57
Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am J Physiol (1976) 1.56
Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J Neuroimmunol (2001) 1.52
Human blood-brain barrier transferrin receptor. Metabolism (1987) 1.50
Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid. J Nucl Med (1991) 1.50
Lipid solubility and drug penetration of the blood brain barrier. Proc Soc Exp Biol Med (1974) 1.48
Human blood-brain barrier insulin receptor. J Neurochem (1985) 1.47
Glucose transport and phosphorylation: which is rate limiting for brain glucose utilization? Ann Neurol (1994) 1.46
Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest (1997) 1.43
Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem (1987) 1.42
Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest (1979) 1.42
Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A (2000) 1.42
Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res (1987) 1.42
Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection. Science (1972) 1.40
Bioavailable testosterone in salivary glands. Clin Chem (1991) 1.39
The use and promise of nuclear magnetic resonance imaging in epilepsy. Epilepsia (1984) 1.39
Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc Natl Acad Sci U S A (1989) 1.39
Terminal endothelial cells of lymph capillaries as active transport structures involved in the formation of lymph in rat skin. Lymphology (1993) 1.38
Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest (1997) 1.37
Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med (1993) 1.37
Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev (1986) 1.35
Kinetics of blood-brain barrier transport of pyruvate, lactate and glucose in suckling, weanling and adult rats. J Neurochem (1979) 1.33
Kinetics of blood-brain transport of hexoses. Biochim Biophys Acta (1975) 1.32
Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res (2000) 1.31
Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am J Physiol (1973) 1.29
Brain extracellular space and the sink action of cerebrospinal fluid. Measurement of rabbit brain extracellular space using sucrose labeled with carbon 14. Arch Neurol (1967) 1.25
Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc Natl Acad Sci U S A (1991) 1.24
Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Brain Res Mol Brain Res (1994) 1.20
hnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivo. Biochem Biophys Res Commun (1999) 1.19
Neuroprotection with noninvasive neurotrophin delivery to the brain. Proc Natl Acad Sci U S A (1999) 1.19
Changes during development in transport processes of the blood-brain barrier. Biochim Biophys Acta (1976) 1.18
Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard. Brain Res (1970) 1.17
Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem (1977) 1.16
Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci U S A (2001) 1.15
Dose dependent reduction of glucose utilization by pentobarbital in rat brain. Stroke (1978) 1.13
Transport of protein-bound hormones into tissues in vivo. Endocr Rev (1981) 1.12
GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. Invest Ophthalmol Vis Sci (1994) 1.12
Kinetic analysis of blood-brain barrier transport of amino acids. Biochim Biophys Acta (1975) 1.11
High molecular weight Alzheimer's disease amyloid peptide immunoreactivity in human serum and CSF is an immunoglobulin G. Biochem Biophys Res Commun (1987) 1.11
Blood-brain barrier genomics. J Cereb Blood Flow Metab (2001) 1.11
Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes (1995) 1.11
Bioavailability of albumin-bound testosterone. J Clin Endocrinol Metab (1985) 1.10
Brain amyloid and Alzheimer disease. Ann Intern Med (1988) 1.10
Rapid transferrin efflux from brain to blood across the blood-brain barrier. J Neurochem (2001) 1.10
Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex. Proc Natl Acad Sci U S A (1995) 1.10
Epilepsy and the blood-brain barrier. Adv Neurol (1986) 1.10
Radioisotope measurement of brain blood turnover time as a clinical index of brain circulation. J Nucl Med (1967) 1.09
Blood-brain barrier restriction of peptides and the low uptake of enkephalins. Endocrinology (1978) 1.08
Transport of [125I]transferrin through the rat blood-brain barrier. Brain Res (1995) 1.08
Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab Dispos (1997) 1.08
Interference of scalp and skull with external measurements of brain isotope content. 1. Isotope content of scalp and skull. J Nucl Med (1969) 1.07
Distribution of various classes of radiolabeled tracers in plasma, scalp, and brain. J Nucl Med (1972) 1.07
Carrier-mediated transport of thyroid hormones through the rat blood-brain barrier: primary role of albumin-bound hormone. Endocrinology (1979) 1.06
Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am J Pathol (1990) 1.06
Human blood-brain barrier insulin-like growth factor receptor. Metabolism (1988) 1.05
Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo. Bioconjug Chem (2001) 1.04
Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab (1986) 1.04
Up-regulation of blood-brain barrier short-form leptin receptor gene products in rats fed a high fat diet. J Neurochem (1998) 1.03
Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue. Am J Physiol (1994) 1.03
The quest for an image of brain: a brief historical and technical review of brain imaging techniques. Neurology (1978) 1.03
Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes. Pharm Res (2001) 1.03
Saturation of blood brain barrier transport of amino acids in phenylketonuria. Arch Neurol (1973) 1.02
Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier. Cancer Res (1999) 1.02
P-Glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries. Brain Res (1999) 1.01
Independent blood-brain barrier transport systems for nucleic acid precursors. Biochim Biophys Acta (1975) 1.01
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc Natl Acad Sci U S A (1993) 1.01
Neutral amino acid transport at the human blood-brain barrier. J Biol Chem (1988) 1.01
Absence of albumin receptor on brain capillaries in vivo or in vitro. Am J Physiol (1985) 1.00
Hematocrit of the human cranial blood pool. Circ Res (1965) 1.00
Rapid sequestration and degradation of somatostatin analogues by isolated brain microvessels. J Neurochem (1985) 0.99
Carrier mediated blood-brain barrier transport of choline and certain choline analogs. J Neurochem (1978) 0.99
Phenylalanine transport at the human blood-brain barrier. Studies with isolated human brain capillaries. J Biol Chem (1986) 0.99
Blood-brain barrier: interface between internal medicine and the brain. Ann Intern Med (1986) 0.99
Immunohistochemical study of cerebral amyloid angiopathy. II. Enhancement of immunostaining using formic acid pretreatment of tissue sections. Am J Pathol (1988) 0.98